论文部分内容阅读
目的观察雷贝拉唑联合莫沙必利治疗胃食管反流病的临床效果。方法 80例胃食管反流病患者,随机分为试验组和对照组,各40例。其中,给予对照组患者雷贝拉唑治疗,在此基础上,给予试验组患者莫沙必利治疗。观察单纯雷贝拉唑治疗与雷贝拉唑联合莫沙必利治疗的临床效果。结果对照组患者中,治疗显效17例,有效15例,无效8例,治疗总有效率为80.0%。试验组患者中,治疗显效21例,有效18例,无效1例,治疗总有效率为97.5%。与对照组相比,试验组的治疗效率明显较高,两组差异具有统计学意义(P<0.05)。结论在治疗胃食管反流病患者过程中,使用雷贝拉唑联合莫沙必利治疗方法可取得满意的治疗效果,具有更高的治疗效率,具有较高的临床推广价值。
Objective To observe the clinical efficacy of rabeprazole combined with mosapride in the treatment of gastroesophageal reflux disease. Methods 80 patients with gastroesophageal reflux disease were randomly divided into experimental group and control group, 40 cases each. Among them, rabeprazole was given to patients in the control group, and on the basis of this, mosapride was given to the patients in the test group. To observe the clinical efficacy of rabeprazole alone and rabeprazole in combination with mosapride. Results In the control group, the treatment was effective in 17 cases, effective in 15 cases and ineffective in 8 cases. The total effective rate was 80.0%. In the experimental group, 21 cases were markedly effective, 18 cases were effective and 1 case was ineffective. The total effective rate was 97.5%. Compared with the control group, the experimental group’s treatment efficiency was significantly higher, the difference between the two groups was statistically significant (P <0.05). Conclusion In the treatment of patients with gastroesophageal reflux disease, the use of rabeprazole combined with mosapride treatment can be satisfied with the treatment effect, with higher efficiency, with high clinical value.